Revuforj (revumenib) is an oral, first-in-class, selective menin inhibitor that is FDA approved for the treatment of relapsed or refractory (R/R) acute leukemia with a lysine methyltransferase 2A gene ...

Here's what happened to the original cast of Hawaii Five-O after it went off the air. "Book 'em, Danno!" the gruff detective ...

We often see heart attacks as sudden, dramatic events, often depicted on television. It shows someone clutching their chest, ...

Exo has obtained 510(k) clearance for two AI-based apps that detect two common lung conditions with its Exo Iris POCUS device ...

A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and ...

WWE legend Ric Flair has informed fans that he must scrap a scheduled meet and greet due to ‘ health issues’. The 76-year-old ...

China: A new population-based cohort study has found a significant U-shaped relationship between the hemoglobin glycation index (HGI) and the risk of cardiovascular disease (CVD), including heart ...

During a live event, John S. Renshaw, MD, and other oncologists discussed various trials of novel regimens for patients with ...

India is seeing a rise in COVID-19 cases, with 7,154 active infections as per the Health Ministry on June 12, 2025. The surge ...

Robust responses observed across subgroups, regardless of co-mutations, number of prior lines of therapy, or prior venetoclax, within efficacy-evaluable pivotal R/R mNPM1 AML population – – 60% (3/5) ...

China: A new study published in BMC Pulmonary Medicine highlights a significant association between elevated blood eosinophil ...

Travere Therapeutics today announced that the Company will present three abstracts at the upcoming International Podocyte Conference.